查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997137

醫療物聯網市場：2026-2032年全球市場預測（按設備類型、組件、連接技術、應用、最終用戶和部署模式分類）

Internet of Medical Things Market by Device Type, Component, Connectivity Technology, Application, End Use, Deployment Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療物聯網市場規模將達到 13.5 億美元，到 2026 年將成長至 17.4 億美元，到 2032 年將達到 79.5 億美元，複合年成長率為 28.76%。

主要市場統計數據
基準年 2025 13.5億美元
預計年份：2026年 17.4億美元
預測年份 2032 79.5億美元
複合年成長率 (%) 28.76%

物聯網在醫療保健領域如何改變臨床護理服務、資料流和技術生態系統，從而實現以患者為中心的持續醫療保健體驗。

醫療物聯網 (IoMT) 透過整合整個醫療資產的連接性和智慧，正在重新定義臨床工作流程、病人參與和設備生命週期。曾經孤立的設備現在可以傳輸連續的數據流，使臨床醫生能夠從間歇性接觸轉變為長期護理。隨著醫療系統將聯網感測器、軟體平台和決策支援工具整合到日常實踐中，這種轉變進一步凸顯了互通性、安全性和人性化的設計的重要性。

關鍵的技術、臨床和商業性轉折點正在重新定義互聯醫療保健領域的設備設計、連接方式和上市時間模式。

互聯醫療設備領域正經歷一場變革，其驅動力包括技術成熟、醫療模式演進以及經濟獎勵機制的轉變。首先，邊緣運算架構的採用正在加速，它將分析處理能力更靠近設備，從而降低了手術遙測和封閉回路型藥物輸送等對時間要求較高的應用中的延遲。這種轉變不僅能夠實現即時決策支持，也重新定義了設備製造商和IT團隊在部署安全邊緣協定堆疊方面的責任。

醫療器械製造商和醫療連網型設備針對新關稅政策對互聯醫療設備供應鏈造成的破壞性影響所採取的策略和營運應對措施。

美國將於2025年實施的新關稅為物聯網醫療（IoMT）供應鏈中的相關人員帶來了一系列複雜的營運和策略考量。關稅政策正在影響連接模組和專用感測器等進口組件的成本，從而影響採購決策、合約談判和產品組合的權衡取捨。為此，許多公司正在採取近岸外包、雙重採購和供應商重組等措施，以降低風險並維持生產的連續性。

設備分類、組件配置、應用領域、連接通訊協定、醫療保健環境和部署模型等方面的細分對策略重點的影響。

細分市場洞察揭示了設備類型、組件、應用、連接技術、終端使用環境和部署模式等方面的獨特動態，從而影響投資重點和整合複雜性。植入式設備、固定式醫院設備和消費級穿戴式裝置等各類設備都具有獨特的臨床風險特徵和生命週期限制，這決定了檢驗和上市後監測方法的嚴謹性。同時，每個組件——連接模組、感測器、服務和軟體——都有其固有的技術依賴性。感測器決定訊號保真度和校準需求；連接模組影響網路相容性和功耗預算；軟體提供分析功能和使用者體驗；專業服務透過臨床整合和培訓來支援成功部署。

影響美洲、歐洲、中東和非洲以及亞太地區商業性成功的設備採用、監管合規性和策略夥伴的區域特徵。

區域趨勢正在塑造美洲、歐洲、中東和非洲以及亞太地區的需求模式、監管應對措施和夥伴關係模式，為每個地區創造了獨特的應用和商業化路徑。在美洲，保險公司對慢性病管理和遠距監測創新技術的濃厚興趣正推動這些技術快速整合到門診和居家醫療計畫中，這構成了市場活躍的顯著特徵。與現有電子健康記錄系統的互通性以及強大的安全框架在該地區至關重要，這就要求供應商提供經過認證的整合解決方案和合規性文件。

市場領先的公司如何整合硬體、連接、軟體和臨床服務，並透過平台化、夥伴關係和卓越營運實現差異化，並將安全性視為首要任務？

物聯網醫療（IoMT）領域的主要企業正在轉型，不再僅僅提供獨立的硬體和軟體，而是提供融合設備專業知識、連接管理和臨床服務的整合解決方案。供應商正投資於模組化平台，以加速不同設備型號的認證，同時支援迭代軟體更新和分析功能的部署。設備製造商、網路營運商、雲端服務供應商和臨床系統整合商之間的策略夥伴關係日益普遍，這些合作縮短了整合時間，並透過互補能力分散了風險。

透過工程、夥伴關係與管治，為製造商和供應商提供實際的策略措施，以加速部署、降低風險並提供持續價值。

產業領導者應優先採取一系列切實可行的步驟，將技術潛力轉化為永續的臨床和商業性優勢。首先，投資於模組化工程和標準化介面，以降低跨多個型號和地區進行設備認證所需的成本和時間。透過建構可重複使用的軟體堆疊和檢驗的硬體模組，企業可以在保持臨床可靠性的同時加快產品上市速度。其次，採用混合連接策略，使無線方案選擇、功耗預算和邊緣處理能力與每個應用情境的特定需求相匹配，從而最佳化效能並降低生命週期成本。

研究途徑透明的混合方法，結合與關鍵相關人員的訪談、技術審查、監管分析和供應鏈映射，確保獲得可靠的見解。

本分析所依據的研究採用了一種混合方法，結合了對關鍵相關人員的訪談、技術文獻綜述、監管指南以及供應鏈文件的分析，從而整體情況。其中一項重點工作是與設備工程師、臨床負責人、採購負責人和網路架構師進行結構化討論，以確定營運限制和優先標準。隨後，將這些定性見解與產品技術規範、已發布的醫療設備互通性標準以及公開的法律規範進行比較，以檢驗模式並識別新興趨勢。

技術成熟度、監管複雜性和商業性創新之間的相互作用將決定哪些組織能夠將互聯設備的潛力轉化為永續的臨床和經濟價值。

總而言之，醫療物聯網 (IoMT) 正從實驗階段邁向現代醫療服務的基礎要素，這需要工程、臨床和商業等各職能部門的通力合作。能夠使設備設計與實際工作流程相契合、建立穩健的供應鏈並優先考慮安全性和互通性的機構，將更有能力創造永續的價值。為了因應不斷變化的價格系統和區域監管差異，情境規劃以及與供應商的積極合作對於確保服務的連續性和成本效益至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療物聯網市場：依設備類型分類

  • 嵌入式裝置
  • 固定設備
  • 穿戴式裝置

第9章：醫療物聯網市場：依組件分類

  • 連接模組
  • 感應器
  • 服務
  • 軟體

第10章：醫療物聯網市場：依連結技術分類

  • Bluetooth Low Energy
  • 蜂巢式物聯網
  • LPWAN
  • Wi-Fi
  • Zigbee

第11章 醫療物聯網市場：依應用領域分類

  • 資產追蹤
  • 慢性病管理
  • 藥物輸送
  • 遠端患者監護
  • 手術遙測

第12章 醫療物聯網市場：依最終用途分類

  • 診所
  • 診斷中心
  • 居家醫療
  • 醫院

第13章：醫療物聯網市場：依部署模式分類

  • 雲
  • 現場

第14章：醫療物聯網市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：醫療物聯網市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：醫療物聯網市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 美國醫療物聯網市場

第18章 中國醫療物聯網市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Apple Inc.
  • Biotronik SE
  • Boston Scientific Corp.
  • Cisco Systems, Inc.
  • Dexcom, Inc.
  • GE HealthCare
  • Google LLC
  • IBM Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic plc
  • Omron Healthcare
  • ResMed Inc.
  • Siemens Healthineers
Product Code: MRR-8903005C49F7

The Internet of Medical Things Market was valued at USD 1.35 billion in 2025 and is projected to grow to USD 1.74 billion in 2026, with a CAGR of 28.76%, reaching USD 7.95 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.35 billion
Estimated Year [2026] USD 1.74 billion
Forecast Year [2032] USD 7.95 billion
CAGR (%) 28.76%

How the Internet of Medical Things is reshaping clinical care delivery, data flows, and technology ecosystems to enable continuous patient-centric healthcare experiences

The Internet of Medical Things (IoMT) is redefining clinical workflows, patient engagement, and device lifecycles by embedding connectivity and intelligence across medical assets. Devices that were once isolated now transmit continuous data streams, enabling clinicians to move from episodic contact toward longitudinal care. This shift amplifies the importance of interoperability, security, and human-centered design as healthcare systems integrate networked sensors, software platforms, and decision-support tools into routine practice.

As converging advances in miniaturization, low-power radios, and cloud-native analytics expand possibilities, stakeholders are navigating a complex set of trade-offs between clinical value, regulatory compliance, and total cost of ownership. Providers must balance the promise of improved outcomes with practical constraints around integration with electronic health records, clinician workflows, and reimbursement mechanisms. Meanwhile, patients expect seamless experiences that preserve privacy and deliver tangible benefits in convenience and clinical insight.

Taking this into account, strategic leaders need to adopt a systems perspective: aligning device portfolios, network strategies, and data governance frameworks to unlock the full potential of connected care. The introduction of new connectivity paradigms and evolving regulatory expectations further underscore the importance of proactive planning, cross-functional collaboration, and iterative validation to translate technological capability into measurable clinical and operational value.

Key technological, clinical, and commercial inflection points that are redefining device design, connectivity approaches, and go-to-market models across connected healthcare

The landscape of connected medical devices is undergoing transformative shifts driven by technological maturation, evolving care models, and changing economic incentives. First, there is accelerated adoption of edge computing architectures that push analytics closer to devices, reducing latency for time-sensitive applications like surgical telemetry and closed-loop drug delivery. This transition is enabling real-time decision support while also reshaping responsibilities for device makers and IT teams in deploying secure edge stacks.

Second, the proliferation of low-power wide-area and 5G-capable cellular technologies is broadening use cases for remote patient monitoring and asset tracking, allowing deployments in both urban and rural contexts. These changes are complemented by advances in sensor fidelity and battery technology, which extend operational life for wearable and implantable devices and reduce maintenance burdens.

Third, business models are shifting from product-centric to service-oriented arrangements, with greater emphasis on subscription-based software, outcome-based contracting, and managed connectivity services. Consequently, manufacturers and health systems are forging new commercial partnerships and embedding post-sale services into device value propositions. Taken together, these shifts are rewriting competitive dynamics and compelling organizations to reassess product roadmaps, regulatory strategies, and partner ecosystems in order to capture value across the connected-care continuum.

Strategic and operational responses from device makers and healthcare organizations to the disruptive effects of new tariff policies on the medical connected-device supply chain

The introduction of new tariffs by the United States in 2025 has introduced a complex set of operational and strategic considerations for stakeholders in the IoMT supply chain. Tariff policy affects the cost basis of imported components such as connectivity modules and specialized sensors, thereby influencing sourcing decisions, contract negotiations, and product configuration trade-offs. In response, many firms have pursued a combination of nearshoring, dual sourcing, and supplier redesign to mitigate exposure and preserve manufacturing continuity.

Moreover, the tariff environment has heightened the importance of supply chain transparency and cost engineering. Companies are reassessing Bill of Materials structures and collaborating more closely with contract manufacturers to identify opportunities for domestic content substitution without degrading clinical performance. At the same time, regulatory compliance and quality system constraints limit the speed at which critical components can be swapped, prompting firms to stage mitigation plans that prioritize clinical safety and validation timelines.

Transitioning strategies also extend to commercial models: providers and device makers are renegotiating service contracts and total cost of ownership frameworks to reflect shifting component costs. Ultimately, the 2025 tariff changes have reinforced the need for more agile procurement, deeper supplier relationships, and scenario-driven planning to sustain device availability and protect service continuity for patients and clinicians.

How differentiated segmentation across device classes, component stacks, application domains, connectivity protocols, care settings, and deployment modes shapes strategic priorities

Segmentation insights reveal differentiated dynamics across device types, components, applications, connectivity technologies, end-use settings, and deployment modes that shape investment priorities and integration complexity. Device types such as implantable devices, stationary hospital equipment, and consumer-grade wearables present distinct clinical risk profiles and lifecycle constraints that determine validation intensity and post-market surveillance approaches. Meanwhile, components including connectivity modules, sensors, services, and software each carry unique technical dependencies: sensors dictate signal fidelity and calibration needs, connectivity modules drive network compatibility and power budgets, software delivers analytics and user experience, and professional services anchor deployment success through clinical integration and training.

Application areas ranging from asset tracking and chronic disease management to drug delivery, remote patient monitoring, and surgical telemetry demand tailored architectures; telemetry use cases require deterministic latency and rigorous certification pathways, whereas chronic disease management emphasizes patient engagement, adherence, and long-term data aggregation. Connectivity technology choices such as Bluetooth Low Energy, cellular IoT, LPWAN, Wi-Fi, and Zigbee influence device power profiles, range, and scalability, with practical trade-offs for indoor versus wide-area deployments. End-use contexts including clinics, diagnostics centers, home healthcare, and hospitals impose different interoperability expectations, security postures, and clinician support models. Finally, deployment mode-cloud or on premises-affects data sovereignty, latency, and operational control, guiding decisions about edge processing, cloud analytics, and integration with institutional IT stacks. Together, these segmentation lenses inform prioritization of design features, partner selection, and commercialization pathways across the IoMT ecosystem.

The regional contours of device adoption, regulatory navigation, and partner strategies that determine commercial success across the Americas, EMEA, and Asia-Pacific

Regional dynamics shape demand patterns, regulatory approaches, and partnership models across the Americas, EMEA, and Asia-Pacific, creating region-specific vectors for adoption and commercialization. In the Americas, market activity is characterized by rapid integration into ambulatory care and home-health programs, driven by payer interest in chronic disease management and remote monitoring innovations. This region emphasizes interoperability with established electronic health record systems and robust security frameworks, compelling vendors to provide certified integrations and compliance-ready documentation.

Europe, the Middle East, and Africa present a mosaic of regulatory regimes and procurement models, where harmonization efforts and regional data-protection standards influence device labeling, clinical evidence requirements, and cross-border data transfers. Public procurement in several markets favors total-cost-of-care propositions, which encourages vendors to demonstrate clinical outcomes and long-term service models. In contrast, Asia-Pacific shows accelerated device deployment in both consumer and institutional channels, propelled by strong manufacturing ecosystems, government-led digital health initiatives, and rapid adoption of mobile-first connectivity. Across regions, local partner ecosystems and regulatory navigation capabilities are decisive factors for successful market entry and scale-up. Consequently, firms must craft geospecific go-to-market approaches that align product attributes, reimbursement strategies, and compliance investments with regional priorities and healthcare delivery structures.

How market leaders are integrating hardware, connectivity, software, and clinical services to differentiate through platformization, partnerships, and security-first operational excellence

Leading companies in the IoMT landscape are evolving beyond discrete hardware or software offerings toward integrated solutions that combine device expertise, connectivity management, and clinical services. Vendors are investing in modular platforms that accelerate certification across device variants while enabling iterative software updates and analytics rollouts. Strategic partnerships between device manufacturers, network operators, cloud providers, and clinical systems integrators are increasingly common, as these alliances reduce time to integration and distribute risk across complementary capabilities.

Corporate differentiation now often centers on demonstrated clinical workflows, depth of post-market support, and robustness of cybersecurity practices. Firms that embed rigorous security-by-design and provide transparent vulnerability management processes earn greater trust among health systems. Additionally, companies that offer flexible commercial models-such as outcomes-linked services, managed connectivity, and bundled analytics-are positioning themselves to capture long-term value beyond initial device sales. Operational excellence in quality systems, clinical evidence generation, and regulatory submissions remains a core competency, and organizations that streamline these functions through standardized processes and reusable technical files can accelerate product iterations while maintaining compliance.

Practical strategic moves for manufacturers and providers to accelerate adoption, reduce risk, and capture recurring value through engineering, partnerships, and governance

Industry leaders should prioritize a set of actionable measures to convert technological promise into sustainable clinical and commercial advantage. First, invest in modular engineering and standardized interfaces to reduce the cost and time required for device certification across multiple variants and geographies. By building reusable software stacks and validated hardware modules, organizations can accelerate market entry while preserving clinical reliability. Second, adopt a hybrid connectivity strategy that aligns radio selections, power budgets, and edge-processing capabilities with the specific needs of each clinical use case to optimize performance and lifecycle costs.

Third, embed security and privacy principles from concept through post-market surveillance, with clear governance for incident response, patching, and vulnerability disclosure. Fourth, deepen partnerships with clinical stakeholders and systems integrators to co-develop workflows and evidence packages that demonstrate measurable clinical benefits. Fifth, strengthen supply chain resilience through diversified sourcing, strategic inventory buffers for critical components, and long-term collaboration agreements with key suppliers. Finally, commercial teams should craft flexible pricing and service models that reflect clinical outcomes and total cost of ownership considerations, thereby aligning incentives across manufacturers, providers, and payers. Implementing these actions will help organizations reduce risk, improve adoption rates, and unlock recurring revenue opportunities.

A transparent mixed-methods research approach combining primary stakeholder interviews, technical reviews, regulatory analysis, and supply chain mapping to ensure robust insights

The research underpinning this analysis draws on a mixed-methods approach that integrates primary stakeholder interviews, technical literature review, regulatory guidance, and supply chain document analysis to ensure a holistic view of the IoMT ecosystem. Primary engagements included structured discussions with device engineers, clinical leads, procurement officers, and network architects to surface operational constraints and prioritization criteria. These qualitative insights were triangulated with product technical specifications, published standards for medical device interoperability, and publicly available regulatory frameworks to validate patterns and identify emergent trajectories.

In parallel, supply chain mappings and component sourcing assessments were performed to illuminate vulnerability nodes and common mitigation strategies. Comparative analysis across connectivity technologies and deployment modes informed trade-off matrices that emphasize latency, power consumption, and integration complexity. Throughout, methodological rigor was maintained by applying reproducible analytical frameworks, documenting assumptions, and subjecting findings to internal peer review. This blended approach ensures that recommendations are grounded in operational realities and reflect the interplay between clinical requirements, engineering constraints, and commercial incentives.

Converging technological maturity, regulatory complexity, and commercial innovation that will determine which organizations convert connected-device potential into sustained clinical and economic value

In summary, the Internet of Medical Things is transitioning from experimental deployments to foundational elements of modern care delivery, demanding coordinated strategies across engineering, clinical, and commercial functions. Organizations that align device design with real-world workflows, implement resilient supply chains, and prioritize security and interoperability will be best positioned to realize durable value. The evolving tariff environment and regional regulatory heterogeneity require scenario planning and proactive supplier engagement to safeguard continuity and cost-effectiveness.

As the ecosystem matures, success will depend on the ability to offer end-to-end solutions that combine reliable hardware, adaptable connectivity, clinically validated software, and meaningful service models. To move from potential to performance, stakeholders must commit to iterative clinical validation, transparent governance, and collaborative partnerships that center patient outcomes. With these priorities in place, the IoMT can materially improve care delivery while creating sustainable economic models for manufacturers, providers, and patients alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Internet of Medical Things Market, by Device Type

  • 8.1. Implantable Devices
  • 8.2. Stationary Devices
  • 8.3. Wearable Devices

9. Internet of Medical Things Market, by Component

  • 9.1. Connectivity Modules
  • 9.2. Sensors
  • 9.3. Services
  • 9.4. Software

10. Internet of Medical Things Market, by Connectivity Technology

  • 10.1. Bluetooth Low Energy
  • 10.2. Cellular IoT
  • 10.3. LPWAN
  • 10.4. Wi-Fi
  • 10.5. Zigbee

11. Internet of Medical Things Market, by Application

  • 11.1. Asset Tracking
  • 11.2. Chronic Disease Management
  • 11.3. Drug Delivery
  • 11.4. Remote Patient Monitoring
  • 11.5. Surgical Telemetry

12. Internet of Medical Things Market, by End Use

  • 12.1. Clinics
  • 12.2. Diagnostics Centers
  • 12.3. Home Healthcare
  • 12.4. Hospitals

13. Internet of Medical Things Market, by Deployment Mode

  • 13.1. Cloud
  • 13.2. On Premises

14. Internet of Medical Things Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Internet of Medical Things Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Internet of Medical Things Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Internet of Medical Things Market

18. China Internet of Medical Things Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Apple Inc.
  • 19.7. Biotronik SE
  • 19.8. Boston Scientific Corp.
  • 19.9. Cisco Systems, Inc.
  • 19.10. Dexcom, Inc.
  • 19.11. GE HealthCare
  • 19.12. Google LLC
  • 19.13. IBM Corporation
  • 19.14. Johnson & Johnson
  • 19.15. Koninklijke Philips N.V.
  • 19.16. Medtronic plc
  • 19.17. Omron Healthcare
  • 19.18. ResMed Inc.
  • 19.19. Siemens Healthineers

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTERNET OF MEDICAL THINGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTERNET OF MEDICAL THINGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES INTERNET OF MEDICAL THINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA INTERNET OF MEDICAL THINGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY STATIONARY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY STATIONARY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY STATIONARY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY BLUETOOTH LOW ENERGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY BLUETOOTH LOW ENERGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY BLUETOOTH LOW ENERGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CELLULAR IOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CELLULAR IOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CELLULAR IOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY LPWAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY LPWAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY LPWAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY WI-FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY WI-FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY WI-FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ZIGBEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ZIGBEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ZIGBEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ASSET TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ASSET TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ASSET TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SURGICAL TELEMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SURGICAL TELEMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY SURGICAL TELEMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ON PREMISES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY ON PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS INTERNET OF MEDICAL THINGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. GCC INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 145. GCC INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. GCC INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. G7 INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 166. G7 INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. NATO INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. NATO INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 173. NATO INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. NATO INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. NATO INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 176. NATO INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTERNET OF MEDICAL THINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES INTERNET OF MEDICAL THINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA INTERNET OF MEDICAL THINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA INTERNET OF MEDICAL THINGS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA INTERNET OF MEDICAL THINGS MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA INTERNET OF MEDICAL THINGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA INTERNET OF MEDICAL THINGS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA INTERNET OF MEDICAL THINGS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)